Your browser version may not work well with NCBI's Web applications. More information here...
1: Nat Cell Biol. 2006 Feb;8(2):188-94. Epub 2006 Jan 15.Click here to read Links

G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis.

Feldman N, Gerson A, Fang J, Li E, Zhang Y, Shinkai Y, Cedar H, Bergman Y.

Department of Experimental Medicine, Hebrew University Medical School, Ein Kerem, Jerusalem 91120, Israel.

Oct-3/4 is a POU domain homeobox gene that is expressed during gametogenesis and in early embryonic cells, where it has been shown to be important for maintaining pluripotency. Following implantation, this gene undergoes a novel multi-step programme of inactivation. Transcriptional repression is followed by a pronounced increase in histone H3 methylation on Lys 9 that is mediated by the SET-containing protein, G9a. This step sets the stage for local heterochromatinization via the binding of HP1 and is required for subsequent de novo methylation at the promoter by the enzymes Dnmt3a/3b. Genetic studies show that these epigenetic changes actually have an important role in the inhibition of Oct-3/4 re-expression, thereby preventing reprogramming.

PMID: 16415856 [PubMed - indexed for MEDLINE]

Related Articles

Patient Drug Information
  • Tretinoin (Vesanoid®) Tretinoin is used to treat acute promyelocytic leukemia (APL; a type of cancer in which there are too many immature blood cells in the blood and bone marrow) in people who have not been helped by other types of chemother...
    » read more ...